Literature DB >> 15668498

Urinary estrogen metabolites and their ratio among Asian American women.

Roni T Falk1, Thomas R Fears, Xia Xu, Robert N Hoover, Malcolm C Pike, Anna H Wu, Abraham M Y Nomura, Laurence N Kolonel, Dee W West, Daniel W Sepkovic, H Leon Bradlow, Regina G Ziegler.   

Abstract

Controversy persists regarding the role of a low ratio of 2-hydroxyestone (2-OHE(1))/16alpha-hydroxyestrone (16alpha-OHE(1)) as a potential estrogen metabolism marker of increased risk for breast cancer. Most of the evidence has been provided by case-control studies, where tumor effects on hormone metabolism are not known. Studies in populations at various risk of breast cancer are not consistent, with some suggesting that levels of the ratio may be altered by changes in diet and exercise. We studied Asian American women participating as controls in a case-control study of breast cancer in which migration history--a composite of the subject's place of birth, type of residence in Asia (urban or rural), length of time living in the West, and grandparents' place of birth--was associated with a 6-fold risk gradient that paralleled the historical differences in incidence rates between the United States and Asian countries. This population offered the possibility to address whether the ratio of 2-OHE(1):16alpha-OHE(1) differs according to recognized breast cancer risk factors, including migration history. Overnight 12-hour urines were obtained from 368 premenopausal and 143 naturally postmenopausal women of Chinese, Japanese, or Filipino descent who donated urines between 1985 and 1988. The estrogen metabolites 2-OHE(1) and 16alpha-OHE(1) were measured with an ELISA kit and adjusted for creatinine levels. In each ethnic group, the ratio of 2-OHE(1):16alpha-OHE(1) was consistently lower in women born in the West than in those who had migrated from Asia. For premenopausal women, the ratio declined 20% due to lower levels of 2-OHE(1). Among postmenopausal women, the ratio was 23% lower in those born in the West, but no consistent patterns based on place of birth were observed for either 2-OHE(1) or 16alpha-OHE(1). The ratio did not vary with most recognized breast cancer risk factors, except for lower metabolite ratios in women with a younger age at first birth and more children, which runs contrary to the hypothesis, because both characteristics reduce breast cancer risk. Our study suggests that the ratio of 2-OHE(1):16alpha-OHE(1) may be a marker for lifestyle influences on estrogen metabolism associated with westernization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668498

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  12 in total

1.  The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.

Authors:  Gertraud Maskarinec; Sreang Heak; Yukiko Morimoto; Laurie Custer; Adrian A Franke
Journal:  Cancer Epidemiol       Date:  2012-04-25       Impact factor: 2.984

Review 2.  A new approach to measuring estrogen exposure and metabolism in epidemiologic studies.

Authors:  R G Ziegler; J M Faupel-Badger; L Y Sue; B J Fuhrman; R T Falk; J Boyd-Morin; M K Henderson; R N Hoover; T D Veenstra; L K Keefer; X Xu
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-09       Impact factor: 4.292

3.  Urinary estrogen metabolites during a randomized soy trial.

Authors:  Yukiko Morimoto; Shannon M Conroy; Ian S Pagano; Marissa Isaki; Adrian A Franke; Frank J Nordt; Gertraud Maskarinec
Journal:  Nutr Cancer       Date:  2012-01-31       Impact factor: 2.900

4.  Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.

Authors:  Joshua N Sampson; Roni T Falk; Catherine Schairer; Steven C Moore; Barbara J Fuhrman; Cher M Dallal; Douglas C Bauer; Joanne F Dorgan; Xiao-Ou Shu; Wei Zheng; Louise A Brinton; Mitchell H Gail; Regina G Ziegler; Xia Xu; Robert N Hoover; Gretchen L Gierach
Journal:  Cancer Res       Date:  2016-12-23       Impact factor: 12.701

5.  Association of estrogen measurements in serum and urine of premenopausal women.

Authors:  Gertraud Maskarinec; Fanchon Beckford; Yukiko Morimoto; Adrian A Franke; Frank Z Stanczyk
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

6.  S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Authors:  Mandeep K Virk-Baker; Stephen Barnes; Helen Krontiras; Tim R Nagy
Journal:  Nutr Res       Date:  2013-12-18       Impact factor: 3.315

7.  Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens.

Authors:  Jessica M Faupel-Badger; Barbara J Fuhrman; Xia Xu; Roni T Falk; Larry K Keefer; Timothy D Veenstra; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

8.  Sex hormone binding globulin in breast cancer.

Authors:  Dayalu Naik S L; Suresh Hedau; Anil Kumar Bahadur; Renuka Saha; Sudershan Kaur; Amitabha Ray
Journal:  Indian J Clin Biochem       Date:  2008-10-01

9.  Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?

Authors:  Nadia Obi; Alina Vrieling; Judith Heinz; Jenny Chang-Claude
Journal:  Int J Womens Health       Date:  2011-02-08

10.  Urinary estrogen levels in women on contraceptives in enugu, South-East Nigeria.

Authors:  Ignatius C Maduka; Francis E Ezeonu; Emeka E Neboh; Elvis N Shu; Ebele J Ikekpeazu
Journal:  J Family Med Prim Care       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.